Counseling help for people with interstitial lung disease
Part of Lungs & breathing clinical trials.
This study tests a counseling program to help people with interstitial lung disease (a group of lung conditions that cause scarring and make breathing harder) with rehabilitation and support. It may help you cope better and stay active.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You are able and willing to give your informed consent to take part.
- You do not have an active cancer diagnosis.
- Your lung condition is stable enough that you can attend follow-up visits without trouble.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a home-based exercise and health coaching program for people with scarring in their lungs (fibrotic ILD). The goal is to see if doing rehab at home, with support from a coach, can help you feel better and breathe easier.
This study tests a home-based program of breathing exercises and physical activity for people with interstitial lung disease, aiming to improve breathlessness and daily function.
This study tests a learning and self-management program for people with pulmonary fibrosis. It helps you better understand and manage your lung condition.
This study aims to improve how doctors diagnose and classify lung conditions that affect both the air sacs and airways, such as COPD and pulmonary fibrosis. By participating, you may help advance medical knowledge and better understand your own condition.
This study tests a rehabilitation program for people with pulmonary fibrosis to help improve their breathing and quality of life. It involves exercise and education, and is designed for those who are medically stable.
This study follows patients with chronic lung scarring (fibrosing interstitial lung disease) who are in the intensive care unit for severe breathing failure. It aims to better understand their condition and care, which may help improve future treatments.
Hear when a new Fibrosis, Pulmonary trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.